Investigating the effect of mobile -based Logotherapy on depressive symptoms, suicidal ideation and hoplessness in patients with major depressive disorder

Investigating the effect of mobile -based Logotherapy on depressive symptoms, suicidal ideation and hoplessness in patients with major depressive disorder reffered to clinics affiliated with Shiraz University of Medical Sciences,1400

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210622051664N1

Enrollment

Registered

2021-07-24

Start date

2021-07-23

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Depression. Condition 2: suicidal ideations. Major depressive disorder, single episode Suicidal ideations

Interventions

Intervention 1: Control group: The control group will remain on the waiting list until the end of the study and will receive only sertraline drug therapy training. Intervention 2: Intervention group:

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having a diagnosis of major depression based on the opinion of a psychiatrist according to DSM-V criteria Having a depression score of 8 or higher based on the short form of the Beck Depression Inventory Have a hoplessness score of 9 or higher based on the Beck Disappointment Questionnaire Having suicidal ideation based on Beck Suicide Thought Questionnaire screening questions Start treatment with the antidepressant drug sertraline based on a psychiatrist's prescription Internet accessible mobile phone

Exclusion criteria

Exclusion criteria: Reluctance to participate in the study Presence of psychotic symptoms in the patient Having other chronic mental disorders such as personality disorders, bipolar disorder or mental retardation in the patient Having chronic physical illnesses such as diabetes or MS Unforeseen physical or mental problems during the intervention Taking other antidepressants except sertraline by the patient The need to hospitalize the patient for any reason, including the high risk of suicide in the patient according to the psychiatrist Incompetence in completing the consent form (such as lack of knowledge of the time, place, person and the presence of psychotic symptoms)

Design outcomes

Primary

Measure	Time frame
Depression. Timepoint: Before the intervention, immediately after the intervention, 3 months later. Method of measurement: Beck Depression Inventory: BDI-11.;Hoplessness. Timepoint: Before the intervention, immediately after the intervention, 3 months later. Method of measurement: Beck hopelessness scale(BHS).;Suicidal thoughts. Timepoint: Before the intervention, immediately after the intervention, 3 months later. Method of measurement: Beck Scale for Suicide Ideation (BSSI).	—

Measure

Time frame

Depression. Timepoint: Before the intervention, immediately after the intervention, 3 months later. Method of measurement: Beck Depression Inventory: BDI-11.;Hoplessness. Timepoint: Before the intervention, immediately after the intervention, 3 months later. Method of measurement: Beck hopelessness scale(BHS).;Suicidal thoughts. Timepoint: Before the intervention, immediately after the intervention, 3 months later. Method of measurement: Beck Scale for Suicide Ideation (BSSI).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Shemiran

Shiraz University of Medical Sciences

farzanehsh80@email.com+98 71 3824 2810

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026